Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,715 INR | +0.29% | +1.55% | -11.01% |
May. 07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
May. 07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 3.37B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Upgrades Gland Pharma to Neutral From Reduce, Adjusts Price Target to INR1,570 From INR1,157